Steven A. Grossman, JD, is President of HPS Group, LLC and a highly respected policy and regulatory consultant and former government official. 

In recognition of his advocacy and policy leadership, he was awarded the Reagan-Udall Foundation for the FDA’s  Innovations in Regulatory Science Award in December 2024. 

In 2006, in response to FDA’s chronic underfunding, Mr. Grossman co-founded and later served as the Executive Director of the Alliance for a Stronger FDA. This multi-stakeholder coalition advocates for increased FDA appropriations and educates policymakers and the public about the agency’s vital mission. 

Since its founding, the Alliance has helped grow the FDA’s appropriated budget from $1.6 billion to $3.5 billion and deepened public understanding of the agency's expanding responsibilities and budget needs. Starting more than a decade ago, Mr. Grossman has written more than five hundred weekly columns analyzing the agency's budget and programs in the context of appropriations. Since the beginning of 2021, he has organized more than 50 hour-long webinars featuring senior FDA leadership. At least a dozen of those webinars have focused exclusively on the food (CFSAN) and veterinary (CVM) centers and on the reorganization of the human foods programs and inspections. 

As President of HPS Group, he has served nine years on the National Organization for Rare Disorders board and continues as a member of the group's Advocacy Committee. 

He also created the FDA Matters website in 2009 and authored over one hundred blog columns over four years. Notably, these columns include a contemporaneous account of the Congressional passage of the Biologics Price Competition and Innovation Act (BPCIA).

From 1989 to 2000, Mr. Grossman was Senior Managing Director at the public affairs/public relations firm of Hill & Knowlton and served various organizations involved with public health and the FDA. 

As part of an assignment to generate awareness and support for pharmaceutical care, he wrote one of the early white papers advocating that vaccines be available in pharmacies and administered by pharmacists. Realizing that goal has profoundly impacted our nation's ability to treat many communicable diseases and served as a backbone of the nation's response to the COVID-19 pandemic.

Mr. Grossman’s advocacy is rooted in public service, having spent six years as counsel and Health Staff Director on the Senate HELP Committee and four years as a Deputy Assistant Secretary for Health at HHS. 

In the Senate, he was one of the chief negotiators on the Orphan Drug Act (ODA) and the Drug Price Competition and Patent Term Restoration Act (known as  Hatch-Waxman). These groundbreaking laws have had a lasting impact on medical innovation and the affordability of pharmaceuticals and have led to profound advances in treatments for individuals with rare diseases. Earlier this year, he was a panelist with Congressman Henry Waxman at the Brookings Institution's event recognizing the 40th Anniversary of Hatch-Waxman.

Mr. Grossman also played a pivotal role in the enactment of the 1984 amendments to the Child Abuse Prevention and Treatment Act. These amendments established needed policies for the treatment of disabled newborns in the United States.

After leaving the Senate, Mr. Grossman continued his dedication to public health as a Deputy Assistant Secretary for Health at HHS. He played a significant role in efforts to address the then-early AIDS/HIV crisis and implement the Orphan Drug Act, including chairing the Orphan Products Board. He led the long-term care component of Secretary Bowen’s initiative on controlling health care costs. 

In 1988, he spent six weeks working at the White House, leading the team that developed President Reagan’s 10-point plan for addressing “the national and international response to the public health threat caused by the Human Immunodeficiency Virus (HIV) infection and the AIDS epidemic.” (https://www.reaganlibrary.gov/archives/speech/message-congress-human-immunodeficiency-virus-epidemic-action-plan). 

Before the Hill, Steven worked as an analyst and advocate for the Association of American Medical Colleges. He played a critical expert role in congressional negotiations over funding medical schools. 

While in law school, Mr. Grossman received a fellowship to work for the Center for State and Local Health Policy, a then-newly founded think tank at Georgetown University that was devoted to expanding the involvement and knowledge levels of state and local health officials. 

Mr. Grossman holds a BA from Oberlin College and a JD from Georgetown University Law School.